Dr George Thomas News Banner Thumbnail

Unlocking The Combination to Target Evasive Kidney Cancers

Roughly one in four people with kidney cancer have a type that does not respond to targeted therapy drugs, leaving no proven treatment options for those whose tumors have started to spread.

“It’s very much an unmet need,” says George Thomas, M.D., whose research team has discovered a potential way to stop these cancers by combining two different targeted agents.

Read the full article here: Blogs.ohsu.edu/Cancer Translated

The journal Cell Reports Medicinpublished the findings online today